Reviva Pharmaceuticals Q3 EPS $(0.17) Beats $(0.29) Estimate

Benzinga · 2d ago
Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.29) by 41.38 percent. This is a 84.4 percent increase over losses of $(1.09) per share from the same period last year.